These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 968404)

  • 1. [Lipoprotein lipase or "clearing factor"].
    Labadie P
    Rev Prat; 1976 Sep; 26(37):2573-6. PubMed ID: 968404
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome].
    Nikiforova NV
    Biull Eksp Biol Med; 1966 Dec; 62(12):29-32. PubMed ID: 6005418
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood clearing factor in infectious hepatitis].
    Malygina-Dudarova SI; Latsinik GE
    Sov Med; 1969 Apr; 32(4):51-3. PubMed ID: 5378879
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research on experimental hyperlipemia. V. Compared effects of the incubation and of the clarifying factor on the blood serum].
    Tayeau F; Jouzier E
    Bord Med; 1970 Sep; 3(9):2023-8. PubMed ID: 5481186
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum lipoprotein lipase activity in diabetes mellitus. II. Hypertriglyceridemia and lipoprotein lipase activity].
    Gligore V; Hîncu N; Ureche A
    Stud Cercet Endocrinol; 1971; 22(1):41-6. PubMed ID: 5565768
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudocholinesterase and lipoprotein lipase in atherosclerosis.
    Hărăguş S; Cucuianu M; Popescu TA
    Cor Vasa; 1972; 14(1):33-41. PubMed ID: 5022129
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipoprotein lipase, intravenous fat tolerance test, and the influence of fat-rich or carbohydrate-rich diet on plasma triglyceride levels in primary hyperglyceridemia.
    Cybulska B; Szostak WB
    Mater Med Pol; 1974; 6(3):169-77. PubMed ID: 4444332
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neonatal hyperlipemia due to lipoprotein lipase deficiency].
    Thouvenot JP; Ghisolfi G; Douste-Blazy L
    Ann Biol Clin (Paris); 1973; 31(2):127-8. PubMed ID: 4356110
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationships of lipoprotein lipase and hyperlipemia in pancreatitis.
    Stackhouse KL; Glass DD; Zimmermann B
    Surg Forum; 1966; 17():343-4. PubMed ID: 5920955
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heparin, lipoprotein lipase and plasma lipids].
    Hollmann M
    Dtsch Med J; 1968 Apr; 19(8):270-8. PubMed ID: 4891142
    [No Abstract]   [Full Text] [Related]  

  • 11. The production of lipaemia-clearing activity in dog plasma after intravenous injection of soya bean phosphatides.
    EDGREN B
    Acta Pharmacol Toxicol (Copenh); 1960; 16():270-81. PubMed ID: 13819318
    [No Abstract]   [Full Text] [Related]  

  • 12. The clearing-factor in obese patients.
    Rodrigues J; Povoa H; Povoa LC
    Acta Biol Med Ger; 1967; 19(2):331-2. PubMed ID: 5591570
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men.
    Kobayashi J; Kusunoki M; Murase Y; Kawashiri M; Higashikata T; Miwa K; Katsuda S; Takata M; Asano A; Nohara A; Inazu A; Mabuchi H
    Horm Metab Res; 2005 Aug; 37(8):505-9. PubMed ID: 16138264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of lipoprotein lipase].
    Murase T
    Nihon Rinsho; 1979 Jun; Suppl():1758-9. PubMed ID: 490987
    [No Abstract]   [Full Text] [Related]  

  • 15. [The clearing factor in relation to the diagnosis and treatment of the atheromasic process].
    ANDREINI A
    G Gerontol; 1960 Aug; 8():559-63. PubMed ID: 13683414
    [No Abstract]   [Full Text] [Related]  

  • 16. Disturbances of lipid metabolism in pancreatic disorders with special reference to serum lipoprotein lipase activity.
    Fujita A
    Nagoya J Med Sci; 1966 Nov; 29(1):1-15. PubMed ID: 5984518
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serum lipoprotein lipase activity in patients with Itsenko-Cushing syndrome].
    Stankusheva T
    Vutr Boles; 1973; 12(3):75-9. PubMed ID: 4752621
    [No Abstract]   [Full Text] [Related]  

  • 18. Dexamethazone and clearing factor.
    Povoa H; Calado AN
    Acta Physiol Lat Am; 1967; 17(4):326-7. PubMed ID: 5616578
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperlipemia and lipoprotein lipase activity in plasma].
    Sailer S
    Wien Z Inn Med; 1965 Nov; 46(11):433-50. PubMed ID: 5331030
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipoprotein lipase and post-heparin esterase activity in primary type IV and V hyperlipoproteinemia].
    Kucerová L; Fabian E; Fabianová J
    Cas Lek Cesk; 1974 Apr; 113(17):519-22. PubMed ID: 4451922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.